CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | Parikh Asit Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-25 | FIELDS HEIDI Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-25 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-05-25 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-19 | Nabulsi Azmi Chief Operating Officer | Grant or award | +12,000 | 33,378 | ||
| 2022-05-19 | Henderson Molly CFO and CBO | Grant or award | +12,000 | 38,000 | ||
| 2022-05-19 | Curran Terrie President and Chief Executive | Grant or award | +12,000 | 76,595 | ||
| 2022-05-16 | Nabulsi Azmi Chief Operating Officer | Purchase | +20,000 | $8.16 | $163K | 785,700 |
| 2022-05-13 | Curran Terrie President and Chief Executive | Purchase | +20,500 | $7.41 | $152K | 64,595 |
| 2022-05-13 | Henderson Molly CFO and CBO | Purchase | +6,000 | 26,000 | ||
| 2022-05-12 | Parikh Asit Director | Purchase | +12,500 | $8.00 | $100K | 12,500 |
| 2022-04-25 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-04-05 | Henderson Molly CFO and CBO | Grant or award | +20,000 | 20,000 | ||
| 2022-04-05 | Henderson Molly CFO and CBO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Option exercise | +7,359,304 | 7,459,304 | ||
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Sale | −18 | $19.00 | $342 | 7,459,286 |
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Option exercise · Warrants | −7,359,304 | 0 | ||
| 2022-01-19 | Nabulsi Azmi Chief Operating Officer | Grant or award | +19,500 | 21,378 | ||
| 2022-01-19 | Nabulsi Azmi Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +97,500 | 97,500 | ||
| 2022-01-19 | Guzzo Anthony J. VP, Chief Accounting Officer | Grant or award | +6,000 | 8,399 |
Page 10 of 19 · 379 trades